Glenmede Trust’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.4M | Sell |
83,480
-8,782
| -10% | -$2.43M | 0.08% | 211 |
|
|
2026
Q1 | $27.2M | Sell |
92,262
-5,057
| -5% | -$1.5M | 0.13% | 130 |
|
|
2025
Q4 | $26.6M | Buy |
+97,319
| New | +$26.4M | 0.13% | 141 |
|
|
2025
Q1 | $27.4M | Buy |
103,209
+4,169
| +4% | +$1.03M | 0.15% | 135 |
|
|
2024
Q4 | $23M | Sell |
99,040
-3,473
| -3% | -$799K | 0.12% | 160 |
|
|
2024
Q3 | $22.6M | Sell |
102,513
-9,555
| -9% | -$1.98M | 0.11% | 184 |
|
|
2024
Q2 | $22M | Sell |
112,068
-9,213
| -8% | -$1.9M | 0.11% | 179 |
|
|
2024
Q1 | $26.1M | Buy |
121,281
+155
| +0.1% | +$32.6K | 0.13% | 160 |
|
|
2023
Q4 | $25.5M | Buy |
121,126
+1,542
| +1% | +$329K | 0.13% | 163 |
|
|
2023
Q3 | $23.9M | Buy |
119,584
+2,726
| +2% | +$542K | 0.14% | 160 |
|
|
2023
Q2 | $22.4M | Sell |
116,858
-159
| -0.1% | -$29.4K | 0.13% | 174 |
|
|
2023
Q1 | $22.4M | Sell |
117,017
-4,602
| -4% | -$832K | 0.13% | 174 |
|
|
2022
Q4 | $20.5M | Buy |
121,619
+113,432
| +1,386% | +$19.7M | 0.12% | 187 |
|
|
2022
Q3 | $1.45M | Sell |
8,187
-7,916
| -49% | -$1.56M | 0.01% | 565 |
|
|
2022
Q2 | $3.29M | Buy |
16,103
+2,522
| +19% | +$535K | 0.02% | 456 |
|
|
2022
Q1 | $3.23M | Buy |
13,581
+7,042
| +108% | +$1.65M | 0.02% | 480 |
|
|
2021
Q4 | $1.49M | Buy |
6,539
+564
| +9% | +$124K | 0.01% | 635 |
|
|
2021
Q3 | $1.15M | Buy |
5,975
+134
| +2% | +$27.1K | 0.01% | 665 |
|
|
2021
Q2 | $1.24M | Sell |
5,841
-812
| -12% | -$171K | 0.01% | 646 |
|
|
2021
Q1 | $1.36M | Buy |
6,653
+634
| +11% | +$125K | 0.01% | 609 |
|
|
2020
Q4 | $1.09M | Buy |
6,019
+8
| +0.1% | +$1.36K | 0.01% | 637 |
|
|
2020
Q3 | $1M | Sell |
6,011
-866
| -13% | -$146K | 0.01% | 618 |
|
|
2020
Q2 | $1.12M | Sell |
6,877
-741
| -10% | -$133K | 0.01% | 587 |
|
|
2020
Q1 | $1.53M | Hold |
7,618
| – | – | 0.01% | 665 |
|
|
2019
Q4 | $1.53M | Buy |
7,618
+1,306
| +21% | +$268K | 0.01% | 665 |
|
|
2019
Q3 | $1.33K | Buy |
6,312
+502
| +9% | +$105K | 0.01% | 679 |
|
|
2019
Q2 | $1.13K | Sell |
5,810
-1,786
| -24% | -$329K | ﹤0.01% | 725 |
|
|
2019
Q1 | $1.25K | Sell |
7,596
-288,124
| -97% | -$50.9M | 0.01% | 711 |
|
|
2018
Q4 | $55.6K | Buy |
295,720
+27,679
| +10% | +$5.11M | 0.27% | 99 |
|
|
2018
Q3 | $45.6M | Buy |
268,041
+100,720
| +60% | +$17M | 0.18% | 172 |
|
|
2018
Q2 | $27.4M | Buy |
167,321
+102,052
| +156% | +$16.7M | 0.12% | 248 |
|
|
2018
Q1 | $9.53M | Hold |
65,269
| – | – | 0.04% | 380 |
|
|
2017
Q4 | $9.53M | Sell |
65,269
-4,108
| -6% | -$585K | 0.04% | 380 |
|
|
2017
Q3 | $9.41M | Buy |
69,377
+4,917
| +8% | +$621K | 0.04% | 369 |
|
|
2017
Q2 | $7.66M | Hold |
64,460
| – | – | 0.04% | 400 |
|
|
2017
Q1 | $7.66M | Sell |
64,460
-1,452
| -2% | -$175K | 0.04% | 400 |
|
|
2016
Q4 | $7.6M | Sell |
65,912
-247,511
| -79% | -$27.5M | 0.04% | 397 |
|
|
2016
Q3 | $32.8M | Sell |
313,423
-37,169
| -11% | -$3.88M | 0.18% | 175 |
|
|
2016
Q2 | $34.1M | Buy |
350,592
+318,075
| +978% | +$30.1M | 0.21% | 157 |
|
|
2016
Q1 | $3.12M | Buy |
32,517
+710
| +2% | +$64.6K | 0.02% | 518 |
|
|
2015
Q4 | $2.88M | Sell |
31,807
-8,702
| -21% | -$819K | 0.02% | 528 |
|
|
2015
Q3 | $3.75M | Sell |
40,509
-120,347
| -75% | -$11.4M | 0.03% | 437 |
|
|
2015
Q2 | $15M | Sell |
160,856
-3,860
| -2% | -$360K | 0.11% | 288 |
|
|
2015
Q1 | $15.6M | Buy |
164,716
+140,592
| +583% | +$13M | 0.11% | 287 |
|
|
2014
Q4 | $2.14M | Buy |
24,124
+10,166
| +73% | +$861K | 0.02% | 556 |
|
|
2014
Q3 | $1.11M | Buy |
13,958
+12,805
| +1,111% | +$965K | 0.01% | 661 |
|
|
2014
Q2 | $80K | Sell |
1,153
-20
| -2% | -$1.41K | ﹤0.01% | 1490 |
|
|
2014
Q1 | $86K | Sell |
1,173
-44
| -4% | -$3.32K | ﹤0.01% | 1478 |
|
|
2013
Q4 | $94K | Buy |
1,217
+70
| +6% | +$5.48K | ﹤0.01% | 1432 |
|
|
2013
Q3 | $84K | Sell |
1,147
-43
| -4% | -$3.17K | ﹤0.01% | 1438 |
|
|
2013
Q2 | $89K | Buy |
+1,190
| New | +$78.1K | ﹤0.01% | 1354 |
|
Other funds holding CME
Glenmede Trust's CME Position: Q2 2026 in Review
Glenmede Trust reduced its CME Group (CME) stake by 9.5% in Q2 2026, selling an estimated $2.43M and leaving 83,480 shares worth $18.4M. The position accounts for 0.08% of the portfolio, ranked #211.
Glenmede Trust first reported a position in CME in Q2 2013 and has held it in 51 quarters since. The position peaked at $45.6M in Q3 2018. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Glenmede Trust held 83,480 shares of CME Group worth $18.4M as of Q2 2026.
- Glenmede Trust sold 8,782 CME Group shares in Q2 2026, an estimated $2.43M.
- CME Group made up 0.08% of Glenmede Trust's portfolio in Q2 2026, its #211 holding.
- Glenmede Trust first reported a position in CME Group in Q2 2013 and has held it in 51 quarters since.
- Glenmede Trust's CME Group position peaked at $45.6M in Q3 2018.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.